San Francisco, California, Nov 02, 2018: A report by TMR Research, titled, “Transfection Reagents and Equipment Market – Global Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 –2025,” states at the outset that transfection entails inserting of nucleic acid and molecules into eukaryotic cells. The most common examples in this area are the introduction of DNA plasmids having gene for expression and small interfering RNA (siRNA).
The global transfection reagents and equipment market is set to soar because of the increasing research in the area of synthetic genetics. It enables modulating gene expressions. Over decades, transfection techniques have found application as analytical tools to help in examining genetic functions, cell growth, protein synthesis, and development. The transfection agents are mainly guided by the type of cell and the existing culture conditions for the assay.
Get Sample Copy of this Report @
Going forward, the global transfection reagents and equipment market is predicted to rise at a healthy clip owing to the progress in transfection technologies. Besides, solid demand from the biotechnology and pharmaceutical companies for research and development is also positively impacting market growth.
A noticeable trend in the global transfection reagents and equipment market is the continued thrust on strategic partnerships and collaborations among key stakeholders, particularly research institutes and pharma companies, to build better products or capture the under tapped market. In fact, cancer research is one of the major drivers of demand.
Based on end users, the global transfection reagents market has been segmented into pharmaceutical companies, biotechnology companies, and research and academic bodies. Based on the methods of transfection, the global transfection reagents market can be divided into physical, viral, and biochemical. Among those, the segment of viral will likely account for maximum market share in the near term.
Read Comprehensive Overview of Report @
Some of the prominent participants in the global transfection reagents and equipment market are Hoffmann-La Roche Ltd., Polyplus-transfection SA, Thermo Fisher Scientific Inc., and Sigma-Aldrich Corporation.